Combined with early clinical evidence for the role of apoE ε4 in the development of cerebral amyloid angiopathy independent of AD [6], and observational associations between dementia and vascular risk factors, these advances have initiated new lines of investigation into whether white matter vasculopathy represents a synergistic or independent mechanism of AD pathogenesis. Here, APOE is linked to Alzheimer disease.